Pure Health Holding Pjsc · ADX:PUREHEALTH
Pure Health Holding Pjsc — PureHealth — 9M 2026 Earnings Presentation
37 slides from Pure Health Holding Pjsc's earnings presentation, November 2026
Slide 1: 9M 2026 Earnings Presentation
Sheikh Tahnoon Bin Mohammed Medical City, Al Ain 9M 2026 Earnings Presentation November 2026
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by PureHealth (the “Company”) for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investment activity, nor does it
Slide 3: Contents
Daman Headquarters, Abu Dhabi Contents Performance Highlights 4 Operational & Strategic Highlights 6 Segment Review 14 Financial Review 24 Outlook & Guidance 31 Appendix 33
Slide 4: A Transformation Leader Across Healthcare and Insurance
9M 2026 Earnings Presentation A Transformation Leader Across Healthcare and Insurance Expanding our Footprint, Deepening our Market Leadership UAE’s Largest UK’s Largest Largest Private Healthcare UAE’s Largest Healthcare Group Private Healthcare Group Group in Greece & Cyprus Health Insurer Circle
Slide 5: 9M 2026 Performance Highlights
9M 2026 Earnings Presentation 9M 2026 Performance Highlights Broad-based growth and sustained profitability across the Group, driven by improving UAE Care activity, continued momentum in International Care and growth in Cover. Group Financial Results (YoY) Care (Healthcare) Cover (Insurance) Hospita
Slide 6: Operational & Strategic Highlights
SEHA Ghiyati Hospital – Al Dhafra, Abu Dhabi Operational & Strategic Highlights
Slide 7: Q3 2026 Key Operational Highlights
9M 2026 Earnings Presentation Q3 2026 Key Operational Highlights Driving strategic growth and value creation through transformation, operational efficiency, technology enablement and synergy delivery Care (Healthcare) DoH Designates SEHA’s STMC as a PureHealth Establishes PureLab UK Global Recogniti
Slide 8: Q3 2026 Key Operational Highlights – cont'd
9M 2026 Earnings Presentation Q3 2026 Key Operational Highlights – cont’d Driving strategic growth and value creation through transformation, operational efficiency, technology enablement and synergy delivery Care (Healthcare) Cover (Insurance) Expanding Robotic Surgery Advancing Diagnostic and Inte
Slide 9: PureCS builds, hosts and runs the Group's AI in-house
9M 2026 Earnings Presentation PureCS, the Group’s dedicated technology company, builds, hosts and runs the Group’s AI in-house Five flagship products run on an AI native operating model, GPU capacity we own and an in-house AI development team LIVE IN DEVELOPMENT (Q1 2027) Pura Doctor Portal Ambient
Slide 10: Sheikh Tahnoon Bin Mohammed Medical City recognised for Clinical Excellence in Stroke Care
9M 2026 Earnings Presentation Sheikh Tahnoon Bin Mohammed Medical City recognised for Clinical Excellence in Stroke Care Designated by the Department of Health (DoH), strengthening specialised care in Al Ain and delivering world-class stroke treatment Advanced, integrated stroke care • Comprehensive
Slide 11: PureLab UK Establishes a Scalable Platform for Diagnostics Growth
9M 2026 Earnings Presentation PureLab UK Establishes a Scalable Platform for Diagnostics Growth Established UK Diagnostic Operations with Clear Value Creation and Significant Capacity Upside 2 London Laboratories Both UKAS accredited ~100K Pathology cases Per Year Established UK Platform Strategic V
Slide 12: International Strategy Delivering Scale, Diversification and Returns
9M 2026 Earnings Presentation International Strategy Delivering Scale, Diversification and Returns Disciplined buy-and-build execution is strengthening PureHealth’s international platform, supporting resilient and profitable growth Our Strategic Approach Diversified, Resilient Footprint with High Re
Slide 13: Segment Review
SEHA Kidney Care – Central, Abu Dhabi Segment Review
Slide 14: Care: Broad-Based Volume Growth Across Key Activity Metrics
9M 2026 Earnings Presentation Care: Broad-Based Volume Growth Across Key Activity Metrics Healthcare Outpatient Volumes Inpatient Volumes (in Thousands) (in Thousands) +51% +51% 249 85 165 +23% 8,324 56 6,784 9M 2025 9M 2026 Q3 2025 Q3 2026 +23% Radiology Volumes1 2,880 (in Thousands) 2,345 +55% +40
Slide 15: UAE Care: Accelerating Volume Growth Driven by Momentum in Patient Activity
9M 2026 Earnings Presentation UAE Care: Accelerating Volume Growth Driven by Momentum in Patient Activity Healthcare +3% +12% +12% Outpatient Volumes (in Thousands) 2,046 1,978 1,773 1,835 1,640 1,682 2025 2026 Q1 Q2 Q3 Inpatient Volumes +10% +9% +19% (in Thousands) 49 43 40 40 41 2025 36 2026 Q1 Q2
Slide 16: UAE Care: Robust Volume Growth and Higher Capacity Utilisation
9M 2026 Earnings Presentation UAE Care: Robust Volume Growth and Higher Capacity Utilisation Healthcare Outpatient Volumes UAE Prescriptions Dispensed (in Thousands) (in Thousands) +14% +9% 5,706 5,248 2,506 2,191 899 +12% +22% 2,046 1,835 735 Q3 2025 Q3 2026 9M 2025 9M 2026 Q3 2025 Q3 2026 9M 2025
Slide 17: UAE Care: Continued Radiology Growth with Lab Volumes Broadly Stable
9M 2026 Earnings Presentation UAE Care: Continued Radiology Growth with Lab Volumes Broadly Stable Healthcare Note: Reduction in lab volumes reflects lower UAE Radiology Volumes UAE Lab Volumes visa screening activity and volumes from (in Thousands) (in Millions) assets operating under capitation mo
Slide 18: UAE Care: Increased Patient Activity and Positive Underlying Growth
9M 2026 Earnings Presentation UAE Care: Increased Patient Activity and Positive Underlying Growth Healthcare Normalised revenue Revenue and Normalised Revenue (in AED Mn) Commentary • 9M'26 reported revenue declined 9.2% YoY, reflecting +9% +6% 10,131 the impact of UPP revenue recognition, internal
Slide 19: UAE Care: Consistent Inpatient Capacity Expansion Across Abu Dhabi
9M 2026 Earnings Presentation UAE Care: Consistent Inpatient Capacity Expansion Across Abu Dhabi Healthcare Inpatient Operational Bed Capacity & Occupancy in Abu Dhabi 75.1% 77.5% 77.7% 80% 3,300 3,064 +10.7 pp 3,100 67.0% 70% FY’23-9M'26 2,900 2,827 2,700 2,624 2,655 60% 2,500 50% 2,300 2,100 +5.3%
Slide 20: International Care: Scaling with Healthy Margins and Continued Momentum
9M 2026 Earnings Presentation International Care: Scaling with Healthy Margins and Continued Momentum Healthcare Total Patient Interactions1 Revenue 7,341 (in Thousands) +73% 2,734 (in AED Mn) +53% +66% +46% 4,810 1,584 870 2,386 525 1,633 Q3 2025 Q3 2026 9M 2025 9M 2026 Q3 2025 Q3 2026 9M 2025 9M 2
Slide 21: Cover: Significant Premium Growth and Higher Claims Activity
9M 2026 Earnings Presentation Cover: Significant Premium Growth and Higher Claims Activity Insurance Gross Written Premium Claims Processed Members Insured (in AED Bn) (in Millions) (in Millions) +14% 6.8 +6% 43.2 40.6 5.9 +2% 3.4 3.3 9M 2025 9M 2026 9M 2025 9M 2026 Solvency Ratio % Investment Incom
Slide 22: Financial Review
Hygeia - Mitera Hospital, Athens, Greece Financial Review
Slide 23: Group: Solid 9M Earnings Growth with Accelerating Q3 Revenue Momentum
9M 2026 Earnings Presentation Group: Solid 9M Earnings Growth with Accelerating Q3 Revenue Momentum Commentary AED Mn Q3 2025 Q3 2026 Δ% 9M 2025 9M 2026 Δ% • Group revenue increased 11.5% YoY in 9M'26, reflecting HHG consolidation (AED 2.3bn) and sustained momentum in Cover and International Care. R
Slide 24: Care: International Scale and Improving UAE Activity Drive Margin Expansion
9M 2026 Earnings Presentation Care: International Scale and Improving UAE Activity Drive Margin Expansion Healthcare Commentary AED Mn Q3 2025 Q3 2026 Δ% 9M 2025 9M 2026 Δ% • Care revenue increased 11.5% YoY in 9M'26, driven by HHG consolidation, growth across the international portfolio and ramping
Slide 25: Cover: Strong 9M Revenue and Earnings Growth
9M 2026 Earnings Presentation Cover: Strong 9M Revenue and Earnings Growth Insurance Commentary AED Mn Q3 2025 Q3 2026 Δ% 9M 2025 9M 2026 Δ% • Cover revenue increased 11.7% YoY to AED 6.4bn in 9M'26, underpinned by 14% GWP growth driven by renewals, pricing discipline and new business momentum. Reve
Slide 26: Cash Conversion Expected to Improve Through Year-End
9M 2026 Earnings Presentation Cash Conversion Expected to Improve Through Year-End AED Mn 9M 2025 9M 2026 Working Capital Changes 9M 2026 EBITDA 3,470 4,178 (in AED Mn) 1 Change in Net Working Capital (2,404) (3,259) Inventories (72) Other operating activities 629 (218) Due from related parties (3,2
Slide 27: Healthy Balance Sheet Supporting Growth and Capital Deployment
9M 2026 Earnings Presentation Healthy Balance Sheet Supporting Growth and Capital Deployment Total Assets (AED Bn) Cash & Bank Balance (AED Bn) Net Debt / EBITDA Commentary • The Group maintains a solid financial position, with total assets of AED 57.3bn, and 57.3 4.2 sufficient liquidity to support
Slide 28: Balanced Approach to Capital Allocation Driving Long-Term Value Creation
9M 2026 Earnings Presentation Balanced Approach to Capital Allocation Driving Long-Term Value Creation Shareholder Returns Inorganic Growth 1 Disciplined Capital Return Policy Clear Strategy to Drive Value Accretive M&A Target annual cash payout of • Pursuing disciplined M&A and bolt-on acquisitions
Slide 29: Outlook & Guidance
Pura Longevity Clinic, SSMC, Abu Dhabi Outlook & Guidance
Slide 30: Medium-Term Strategic and Financial Targets
9M 2026 Earnings Presentation Medium-Term Strategic and Financial Targets Medium-term targets remain unchanged, supported by resilient execution and confidence in the Group’s growth outlook 2 Revenue International Care: EBITDA CAPEX as % Net Debt Dividend 1 Growth Revenue Share Margin of Revenue / E
Slide 31: Appendix
Sheikh Tahnoon Bin Mohammed Medical City, Al Ain Appendix
Slide 32: Overview of Our Integrated Portfolio of Healthcare Assets
9M 2026 Earnings Presentation Overview of Our Integrated Portfolio of Healthcare Assets Care (Healthcare) Cover (Insurance) Hospitals Diagnostics Procurement Technology Health and P&C 1 9M 2026 Segment Value & Contribution in % Revenue AED 17,114 Mn (60%) AED 880 Mn (3%) AED 3,846 Mn (13%) AED 624 M
Slide 33: Focused Expansion in Complex and Specialised Care
9M 2026 Earnings Presentation Focused Expansion in Complex and Specialised Care Expanding Advanced Fetal Therapy Transplants Corniche Hospital performed fetoscopic laser surgery for complex twin Performed 13 liver and 107 kidney transplants in 2026, bringing pregnancies, strengthening its advanced f
Slide 34: Balance Sheet
9M 2026 Earnings Presentation Balance Sheet AED Mn FY 2025 9M 2026 Δ% Total Non-Current Assets 36,657 37,697 3% Right of use assets 12,671 11,987 -5% Intangible Assets 12,568 12,268 -2% Property & equipment 7,397 7,313 -1% Other non-current assets 4,020 6,129 52% Total Current Assets 20,021 19,650 -
Slide 35: Income Statement
9M 2026 Earnings Presentation Income Statement AED Mn Q3 2025 Q3 2026 Δ% 9M 2025 9M 2026 Δ% Revenue 6,527 7,571 16.0% 20,101 22,422 11.5% Cost of sales (4,714) (5,557) 17.9% (14,980) (16,790) 12.1% Gross profit 1,814 2,013 11.0% 5,122 5,632 10.0% G&A expenses incl. selling & distribution (1,355) (1,
Slide 36: Cash Flow Statement
9M 2026 Earnings Presentation Cash Flow Statement AED Mn Q3 2025 Q3 2026 Δ% 9M 2025 9M 2026 Δ% Net Profit for the period before tax 569 591 4% 1,744 1,994 14% Non-cash Adjustments 529 732 38% 1,685 2,135 27% 1 Working Capital Changes 295 -42 -114% -2,404 -3,259 36% Employees’ end of service benefits
Slide 37: Investor Relations
Investor Relations purehealth.ae/investor-relations ir@purehealth.ae